Countries Australia

Chemotherapy may be completed within 8 days with two doses of Polytaxel, an innovative anticancer drug from South Korea's biotech firm

Polytaxel, a novel pain-free anticancer drug, may not require break periods A new standard of care, more convenient than docetaxel, is suggest...

 November 28, 2022 | News

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Obtained marketing approval on the 23rd (local time) from the Therapeutic Goods Administration (TGA) of Australia for the indication of gl...

 November 25, 2022 | News

Australian Scientists Honoured with the Grand Hamdan Award

The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place  on 23rd of ...

 November 25, 2022 | News

Lunit Partners with to Accelerate AI-Powered Medical Imaging Across Major Overseas Channels

Lunit signed a global distribution agreement to provide its AI-based radiology solutions for clinical use via's platform The partnership will d...

 November 24, 2022 | News

First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of Telix's lead therapeutic clinical programs and has been granted orphan drug designation ...

 November 22, 2022 | News

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

The technology is housed in the Monash Antibody Technology Facility (MATF) where researchers not only from Monash University but elsewhere in Victoria...

 November 10, 2022 | News

Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study

Summary of Study Outcomes ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met ...

 November 07, 2022 | News

LUMC to Fund New Clinical Trial of Cynata's Cymerus™ MSCs in Kidney Transplantation

Cynata to collaborate with Leiden University Medical Center (LUMC) in the Netherlands, in a new clinical trial in patients who have received a kidne...

 November 04, 2022 | News

Australia First in-human use of OncoRes Medical's cancer imaging system successful

OncoRes Medical today announces positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The study, titled&n...

 November 03, 2022 | News

Sartorius Enters Research Partnership with The BASE Facility at the University of Queensland

Sartorius entered a research partnership with The BASE Facility at The University of Queensland (UQ) to improve the manufacturing process of nucleic a...

 October 24, 2022 | News

AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

  AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries. Th...

 October 18, 2022 | News

Health Canada Approves Illuccix® for Prostate Cancer Imaging

Illuccix™ [kit for the preparation of gallium (68Ga) gozetotide injection], after radiolabeling with gallium (68Ga), is indicated for use with the po...

 October 14, 2022 | News

First patient treated in Clarity's therapeutic prostate cancer trial

  Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT0...

 October 10, 2022 | News

Australia's Paradigm Biopharmaceuticals reports positive early osteoarthritis drug trial results

Australian repurposing drug company Paradigm Biopharmaceuticals says positive clinical trial results for its osteoarthritis drug candidate indicate a poten...

 October 07, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in